Literature DB >> 1905297

Cooperative enhancement of hyaluronic acid synthesis by combined use of IGF-I and EGF, and inhibition by tyrosine kinase inhibitor genistein, in cultured mesothelial cells from rabbit pericardial cavity.

A Honda1, N Noguchi, H Takehara, Y Ohashi, N Asuwa, Y Mori.   

Abstract

We examined the combined effects of IGF-I and EGF on hyaluronic acid synthesis using cultured pericardial mesothelial cells from rabbit pericardial cavity. Combined exposure of pericardial cells to IGF-I and EGF cooperatively increased hyaluronic acid synthesis and the level of hyaluronic acid synthase activity over that seen with or without IGF-I or EGF alone, but did not significantly stimulate the sulfated glycosaminoglycan synthesis. Increase in the level of hyaluronic acid synthesis and hyaluronic acid synthase activity induced by these growth factors was blocked after pretreatment with a tyrosine-specific protein kinase inhibitor, genistein. Genistein had no direct inhibitory effect on hyaluronic acid synthase activity. These results suggest that cooperative enhancement of hyaluronic acid synthesis induced by combined use of IGF-I and EGF could be mediated by a receptor tyrosine kinase-involved transmembrane signaling process that is responsive to IGF-I and EGF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905297     DOI: 10.1242/jcs.98.1.91

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  8 in total

1.  Acidic glycosaminoglycans of abdominal mucin in a case of pseudomyxoma peritonei caused by appendiceal cancer.

Authors:  T Miyashita; K Murata; E Hoshino; H Nishiya; Y Ono; I Akaoka; O Kunii
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Expression of human hyaluronan synthases in response to external stimuli.

Authors:  A Jacobson; J Brinck; M J Briskin; A P Spicer; P Heldin
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

3.  Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor.

Authors:  M D Basson; I M Modlin; J A Madri
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

4.  Characterization of the molecular mechanism involved in the activation of hyaluronan synthetase by platelet-derived growth factor in human mesothelial cells.

Authors:  P Heldin; T Asplund; D Ytterberg; S Thelin; T C Laurent
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

5.  Prostaglandin E2 stimulates cyclic AMP-mediated hyaluronan synthesis in rabbit pericardial mesothelial cells.

Authors:  A Honda; Y Sekiguchi; Y Mori
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

6.  Modulation of hyaluronan synthase activity in cellular membrane fractions.

Authors:  Davide Vigetti; Anna Genasetti; Evgenia Karousou; Manuela Viola; Moira Clerici; Barbara Bartolini; Paola Moretto; Giancarlo De Luca; Vincent C Hascall; Alberto Passi
Journal:  J Biol Chem       Date:  2009-09-08       Impact factor: 5.157

7.  Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-beta 1 involves activation of protein kinase C.

Authors:  M Suzuki; T Asplund; H Yamashita; C H Heldin; P Heldin
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

Review 8.  The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma.

Authors:  Daisuke Kudo; Akiko Suto; Kenichi Hakamada
Journal:  Int J Mol Sci       Date:  2017-03-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.